Health Technology · Pharmaceuticals: Major · NSE: TORNTPHARM · data 2026-10-09
Torrent Pharmaceuticals Ltd
Health check: Average (5.3/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹4,656.9
Market cap
₹1,77,816 cr
P/E
72.3
P/B
—
ROE
27.1%
ROCE
13.5%
Debt / equity
1.79
Dividend yield
0.81%
1-year return
30.1%
52-week high
₹5,250
52-week low
₹3,480.6
Operating margin
23.3%
Growth
| Revenue (last 12 months) | ₹15,723 cr |
| Net profit (last 12 months) | ₹2,181 cr |
| Sales growth, 3 years (yearly) | 12.5% |
| Profit growth, 3 years (yearly) | 20.2% |
Similar companies
Divi's Laboratories Limited (DIVISLAB) · Zydus Lifesciences Limited (ZYDUSLIFE) · Laurus Labs Ltd. (LAURUSLABS) · Mankind Pharma Ltd. (MANKIND) · Dr. Reddy's Laboratories Ltd. (DRREDDY)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open TORNTPHARM in NSE Scanner →